• OPEN AN ACCOUNT
Indian Indices
Nifty
24,750.70 -82.90
(-0.33%)
Sensex
81,451.01 -182.01
( -0.22%)
Bank Nifty
55,749.70 203.65
( 0.37%)
Nifty IT
37,321.75 -432.40
( -1.15%)
Global Indices
Nasdaq
42,280.67 43.94
(0.10%)
Dow Jones
5,931.28 -1.89
(-0.03%)
Hang Seng
38,097.61 -335.37
(-0.87%)
Nikkei 225
8,772.38 55.93
(0.64%)
Forex
USD-INR
85.50 0.07
(0.09%)
EUR-INR
97.01 0.42
(0.44%)
GBP-INR
115.18 0.03
(0.03%)
JPY-INR
0.59 0.00
(0.53%)

EQUITY - MARKET SCREENER

Cohance Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543064
INE03QK01018
90.9609293
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
COHANCE
97.91
26595.67
EPS(TTM)
Face Value()
Div & Yield %
10.67
1
0
 

Refex Industries consolidated net profit rises 39.83% in the March 2025 quarter
Apr 24,2025
Net profit of Refex Industries rose 39.83% to Rs 47.92 crore in the quarter ended March 2025 as against Rs 34.27 crore during the previous quarter ended March 2024. Sales rose 83.37% to Rs 627.76 crore in the quarter ended March 2025 as against Rs 342.35 crore during the previous quarter ended March 2024.

For the full year,net profit rose 68.72% to Rs 158.38 crore in the year ended March 2025 as against Rs 93.87 crore during the previous year ended March 2024. Sales rose 78.44% to Rs 2467.66 crore in the year ended March 2025 as against Rs 1382.87 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales627.76342.35 83 2467.661382.87 78
OPM %10.1712.05 -8.5010.56 -
PBDT71.1440.72 75 232.48134.87 72
PBT59.5236.56 63 199.91121.33 65
NP47.9234.27 40 158.3893.87 69